© 1995 American Heart Association, Inc.
Articles |
Relative Contributions of Apolipoprotein(a) and Apolipoprotein-B to the Development of Fatty Lesions in the Proximal Aorta of Mice
From the Departments of Internal Medicine and Molecular Genetics (F.P.M., V.M., H.H.H.) and The Howard Hughes Medical Center and Department of Biochemistry (R.E.H.), University of Texas Southwestern Medical Center, Dallas; The Gladstone Institute of Cardiovascular Disease (D.L.N., J.M., S.G.Y., D.A.S.), University of California at San Francisco; and Northwest Lipid Research Laboratory (S.M.), University of Washington, Seattle.
Correspondence to Helen H. Hobbs, MD, Department of Molecular Genetics, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235-9046.
Abstract Transgenic mice expressing transgenes for both human apolipoprotein B-100 (h-apoB) and apolipoprotein(a) [apo(a)] were fed a high-fat, atherogenic diet for 14 weeks to examine the effect of lipoprotein(a) [Lp(a)] on the development of aortic fatty lesions. The extent of lesions in the proximal region of the aorta of Lp(a) mice was measured by use of a computer-assisted image analysis of 20 sections per animal and compared with that of nontransgenic mice as well as mice expressing either the apo(a) or h-apoB transgene. The control (n=23) and apo(a) (n=22) transgenic mice had very small mean lesion areas (607 versus 128 µm2 per section). The h-apoB–expressing mice (n=20) had significantly higher mean lesion areas (3288 µm2 per section) than either the control or apo(a) transgenic animals. Coexpression of apo(a) and h-apoB transgenes resulted in only a modest increase in lesion area (4678 µm2 per section, n=19). Thus, the expression of human apo(a) in C57BL/6/SJL hybrid mice fed an atherogenic diet failed to significantly potentiate the development of aortic fatty lesions in the absence or presence of high levels of h-apoB.
Key Words: apo(a) • lipoprotein(a) • transgenic mice • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  S. M. Marcovina, M. L. Koschinsky, J. J. Albers, and S. Skarlatos Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions Clin. Chem., November 1, 2003; 49(11): 1785 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sun, H. Unoki, X. Wang, J. Liang, T. Ichikawa, Y. Arai, M. Shiomi, S. M. Marcovina, T. Watanabe, and J. Fan Lipoprotein(a) Enhances Advanced Atherosclerosis and Vascular Calcification in WHHL Transgenic Rabbits Expressing Human Apolipoprotein(a) J. Biol. Chem., November 27, 2002; 277(49): 47486 - 47492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Busso, J. Dudler, R. Salvi, V. Peclat, V. Lenain, S. Marcovina, R. Darioli, P. Nicod, A. K. So, and V. Mooser Plasma Apolipoprotein(a) Co-Deposits with Fibrin in Inflammatory Arthritic Joints Am. J. Pathol., October 1, 2001; 159(4): 1445 - 1453. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Ishibashi Lipoprotein(a) and Atherosclerosis Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
J. Fan, H. Shimoyamada, H. Sun, S. Marcovina, K. Honda, and T. Watanabe Transgenic Rabbits Expressing Human Apolipoprotein(a) Develop More Extensive Atherosclerotic Lesions in Response to a Cholesterol-Rich Diet Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 88 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fan, M. Challah, H. Shimoyamada, M. Shiomi, S. Marcovina, and T. Watanabe Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a] J. Lipid Res., June 1, 2000; 41(6): 1004 - 1012. [Abstract] [Full Text]
|
|
|
|
|
|
V. Mooser, M. M. Berger, L. Tappy, C. Cayeux, S. M. Marcovina, R. Darioli, P. Nicod, and R. Chiolero Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1137 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nilausen and H. Meinertz Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein Am. J. Clinical Nutrition, March 1, 1999; 69(3): 419 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Nassir, D. K. Bonen, and N. O. Davidson Apolipoprotein(a) Synthesis and Secretion from Hepatoma Cells Is Coupled to Triglyceride Synthesis and Secretion J. Biol. Chem., July 10, 1998; 273(28): 17793 - 17800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Sanan, D. L. Newland, R. Tao, S. Marcovina, J. Wang, V. Mooser, R. E. Hammer, and H. H. Hobbs Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a) PNAS, April 14, 1998; 95(8): 4544 - 4549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kim and S. G. Young Genetically modified mice for the study of apolipoprotein B J. Lipid Res., April 1, 1998; 39(4): 703 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. A. McCormick, J. K. Ng, C. M. Cham, S. Taylor, S. M. Marcovina, J. P. Segrest, R. E. Hammer, and S. G. Young Transgenic Mice Expressing Human ApoB95 and ApoB97. EVIDENCE THAT SEQUENCES WITHIN THE CARBOXYL-TERMINAL PORTION OF HUMAN apoB100 ARE IMPORTANT FOR THE ASSEMBLY OF LIPOPROTEIN(a) J. Biol. Chem., September 19, 1997; 272(38): 23616 - 23622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Keesler, B. R. Gabel, C. M. Devlin, M. L. Koschinsky, and I. Tabas The Binding Activity of the Macrophage Lipoprotein(a)/Apolipoprotein(a) Receptor Is Induced by Cholesterol via a Post-translational Mechanism and Recognizes Distinct Kringle Domains on Apolipoprotein(a) J. Biol. Chem., December 13, 1996; 271(50): 32096 - 32104. [Abstract] [Full Text] [PDF]
|
|